Drug Trial News

RSS

Promising new therapy for Alzheimer's

NewYork-Presbyterian Hospital/Weill Cornell Medical Center announced today the nine-month interim results of an ongoing Phase II clinical trial of GAMMAGARD Intravenous Immunoglobulin (IGIV) for Alzheimer's disease at the Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) in Chicago.

From Baxter International Inc. 30 Jul 2008

Rember, new Alzheimer's drug offers hope to sufferers

An experimental drug to treat Alzheimer's disease has had some promising results in early trials with patients.

30 Jul 2008

Retirement could be hazardous for the health

A study by the ABS based on 2004-05 health data and labour force statistics on older workers aged 45 to 74, also took into account people not in the workforce and those too ill to work.

30 Jul 2008

Twenty percent of British adult survivors of childhood cancer smoke despite hazards

Twenty percent of British adult survivors of childhood cancers are current smokers, and nearly a third have been regular smokers at some point in their lives, according to a study in the July 29 online issue of the Journal of the National Cancer Institute.

29 Jul 2008

Cholesterol lowering drugs may protect against dementia

A new study has found more evidence that the drugs commonly used to lower cholesterol may also offer protection from dementia and memory loss.

29 Jul 2008

Bladder problems may leave mark on brain contributing to sleep and attention problems

Bladder problems may leave a mark on the brain, by changing patterns of brain activity, possibly contributing to disrupted sleep and problems with attention. For one in six Americans who have overactive bladder, the involuntary bladder contractions that often trigger more frequent urges to urinate, such mind-body connections may be of more than academic interest.

29 Jul 2008

Australian Alzheimer's trial published in the Lancet

Prana Biotechnology Limited announced today the publication of the results of its Phase 2a clinical trial on Alzheimer's disease patients in The Lancet Neurology journal.

29 Jul 2008

Markers in blood and spinal fluid, and a new imaging agent, show promise for early detection of Alzheimer's

With the continued aging of the population and the growing epidemic of Alzheimer's, early detection of the disease is crucial for risk assessment, testing new therapies, and eventual early intervention with better drugs, once they are developed. Four studies reported today at the Alzheimer's Association's 2008 International Conference on Alzheimer's Disease (ICAD 2008) in Chicago bring us closer to that goal of early detection by describing advances in biomarkers.

29 Jul 2008

Alzheimer's disease patients show improvement in trial of new drug

A new drug has been shown to improve the brain function of people with early stage Alzheimer's disease and reduce a key protein associated with the disease in the spinal fluid, in a small study published today in the journal Lancet Neurology and presented at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease.

29 Jul 2008

Laboratory and mouse studies show targeted drug blocks the growth of breast cancer cells that spread to the brain

Using laboratory and mouse models of human breast cancer, researchers have found that a small molecule capable of targeting specific proteins on the surface of breast cancer cells can inhibit the growth of breast cancer cells that migrate to the brain.

29 Jul 2008

Laser therapy more effective than corticosteroids in long term treatment of diabetic macular edema

A promising new drug therapy used to treat abnormal swelling in the eye - a condition called diabetic macular edema - proved less effective than traditional laser treatments in a study funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH).

29 Jul 2008

How mixing medications can be fatal

A large-scale study of home medication consumption has highlighted the danger of mixing drugs.

29 Jul 2008

A daily 45 minute walk limits the impact of diabetes

According to scientists in the UK, by simply walking for an extra 45 minutes a day, people with diabetes can limit the impact of the disease.

29 Jul 2008

Statins reduce the risk of dementia by half

People at high risk for dementia who took cholesterol-lowering statins are half as likely to develop dementia as those who do not take statins, a new study shows.

28 Jul 2008

Most adults in U.S. will be overweight or obese by 2030

Most adults in the U.S. will be overweight or obese by 2030, with related health care spending projected to be as much as $956.9 billion, according to researchers at the Johns Hopkins Bloomberg School of Public Health, the Agency for Healthcare Research and Quality and the University of Pennsylvania School of Medicine. Their results are published in the July 2008 online issue of Obesity.

28 Jul 2008